CDNA · trading date Oct 12, 2026 · previous close $63.64 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$379.81M
Net income
-$21.35M
Total assets
$413.23M
Total liabilities
$110.13M
Stockholders' equity
$303.10M
Cash & equivalents
$65.43M
Operating income
-$30.78M
Operating cash flow
$42.03M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-02-25.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-8.1%
Net margin
-5.6%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
26.7%
Equity / assets
73.3%
CapEx / revenue
—
Operating cash flow / net income
-1.97×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Brisbane, CA 94005
8000 MARINA BLVD
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.